Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXA-REFINE: Higher vs. Lower Doses of Dexamethasone in AHRF
NCT04545242Phase 4Completed
- Sponsor
- Hospital Universitario de Gran Canaria Dr. Negrín
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in acute hypoxemic respiratory failure (AHRF), acute respiratory distress syndrome (ARDS), sponsored by Hospital Universitario de Gran Canaria Dr. Negrín. Started Jul 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
acute hypoxemic respiratory failure (AHRF)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04545242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545242.